| [1] |
Reves R, Schluger NW . Update in tuberculosis and nontuberculous mycobacterial infections 2013. Am J Respir Crit Care Med, 2014,189(8):894-898.
doi: 10.1164/rccm.201402-0210UP
URL
pmid: 24735031
|
| [2] |
中华医学会结核病学分会, 《中华结核和呼吸杂志》编辑委员会. 非结核分枝杆菌病诊断与治疗专家共识. 中华结核和呼吸杂志, 2012,35(8):572-580.
doi: 10.3760/cma.j.issn.1001-0939.2012.08.006
URL
|
| [3] |
中华医学会结核病学分会, 非结核分枝杆菌病实验室诊断专家共识编写组. 非结核分枝杆菌病实验室诊断专家共识. 中华结核和呼吸杂志, 2016,39(6):438-443.
doi: 10.3760/cma.j.issn.1001-0939.2016.06.007
URL
|
| [4] |
沙巍 . 重视非结核分枝杆菌病的规范化诊治. 中国防痨杂志, 2017,39(3):217-219.
doi: 10.3969/j.issn.1000-6621.2017.03.001
URL
|
| [5] |
汪一萍, 鲁勇, 应建飞 , 等. 脓肿分枝杆菌实验室快速检测方法的应用. 中华检验医学杂志, 2015,38(12):861-864.
doi: 10.3760/cma.j.issn.1009-9158.2015.12.016
URL
|
| [6] |
Kendall BA, Varley CD, Choi D , et al. Distinguishing tuberculosis from nontuberculous mycobacteria lung disease, Oregon, USA. Emerg Infect Dis, 2011,17(3):506-509.
doi: 10.3201/eid1703.101164
URL
pmid: 3166013
|
| [7] |
Griffith DE, Aksamit T, Brown-Elliott BA , et al. An official ATS/IDSA statement: diagnosis,treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med, 2007,175(4):367-416.
doi: 10.1164/rccm.200604-571ST
URL
pmid: 17277290
|
| [8] |
Koh WJ, Jeon K, Lee NY , et al. Clinical significance of differen-tiation of Mycobacterium massiliense from Mycobacterium abscessus. Am J Respir Crit Care Med, 2011,183(3):405-410.
doi: 10.1164/rccm.201003-0395OC
URL
pmid: 20833823
|
| [9] |
Stout JE, Koh WJ, Yew WW . Update on pulmonary disease due to non-tuberculous mycobacteria. Int J Infect Dis, 2016,45:123-134.
doi: 10.1016/j.ijid.2016.03.006
URL
pmid: 26976549
|
| [10] |
Kim YK, Hahn S, Uh Y , et al. Comparable characteristics of tuberculous and non-tuberculous mycobacterial cavitary lung diseases. Int J Tuberc Lung Dis, 2014,18(6):725-729.
doi: 10.5588/ijtld.13.0871
URL
pmid: 24903945
|
| [11] |
中国防痨协会. 耐药结核病化学治疗指南(2015). 中国防痨杂志, 2015,37(5):421-469.
doi: 10.3969/j.issn.1000-6621.2015.05.001
URL
|
| [12] |
World Health Organization . Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: World Health Organization, 2014.
doi: 10.1258/ijsa.2010.10e007
URL
pmid: 25320836
|
| [13] |
Nessar R, Cambau E, Reyrat JM , et al. Mycobacterium abscessus: a new antibiotic nightmare. J Antimicrob Chemother, 2012,67(4):810-818.
doi: 10.1093/jac/dkr578
URL
pmid: 22290346
|
| [14] |
Uyan ZS, Ersu R, Oktem S , et al. Mycobacterium abscessus infection in a cystic fibrosis patient:a difficult to treat infection. Int J Tuberc Lung Dis, 2010,14(2):250-251.
|
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.
